Meeting
Abstract Number: 133
SHM Converge 2023
Background: Statin use has been shown to be beneficial in secondary stroke prevention. However, the optimal LDL level that should be achieved is still uncertain. Since there is a dearth of information, it is unclear if statins are useful in patients with stroke with baseline LDL ≤70 mg/dl in terms of morbidity and mortality outcomes. […]
Abstract Number: 534
SHM Converge 2023
Case Presentation: A 69-year-old male with a past medical history of hyperlipidemia on atorvastatin and type 2 diabetes presenting with progressive muscle pain and weakness. Who reports proximal muscle weakness, worsening over four years, and most prominent in the lower extremities. He started atorvastatin approximately one year prior to evaluation and has a family history […]
Abstract Number: 591
SHM Converge 2023
Case Presentation: This case describes a 72-year-old female with previous left pontine cerebrovascular accident (CVA) in 2019, hypertension and hyperlipidemia who presented to the Emergency Department with worsening bilateral shoulder pain and progressive weakness. Two years prior, statin therapy was started for secondary CVA prevention, however, the statin was discontinued because the Patient developed muscle […]